�y��vlog

The next significant modality for prostate cancer treatment is likely radiopharmaceuticals, which target and treat more resistant prostate cancers.

Plans to replace a NHS Greater Glasgow and Clyde facility that manufactures radiopharmaceutical medicines were found to have 31 significant or major risks, including "poor project governance", in a report published last June.

The study tested an emerging class of medicine called radiopharmaceuticals, drugs that deliver radiation directly to cancer cells.

"This will improve significantly both the quality and quantity of radiopharmaceutical products."

The Department of Health and Social Care has asked radiopharmaceutical suppliers to use air freight in the event of a no-deal Brexit, as that is expected to cause road disruption.